146 related articles for article (PubMed ID: 6288570)
1. Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer.
Cho CT; Feng KK; McCarthy VP; Lenahan MF
Infect Immun; 1982 Aug; 37(2):720-7. PubMed ID: 6288570
[TBL] [Abstract][Full Text] [Related]
2. The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis.
Padalko E; Nuyens D; De Palma A; Verbeken E; Aerts JL; De Clercq E; Carmeliet P; Neyts J
Antimicrob Agents Chemother; 2004 Jan; 48(1):267-74. PubMed ID: 14693549
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of coxsackievirus B3 infection in adult mice pretreated with a gold salt.
Kabiri M; Basiri E; Kadivar D
J Med Virol; 1978; 3(2):125-36. PubMed ID: 215719
[TBL] [Abstract][Full Text] [Related]
4. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory effect of LS 2616 and poly I:C in coxsackievirus B3 induced murine myocarditis.
Ilbäck NG; Fohlman J; Friman G
Antiviral Res; 1988 Nov; 10(1-3):129-40. PubMed ID: 2852917
[TBL] [Abstract][Full Text] [Related]
6. Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice.
Lutton CW; Gauntt CJ
J Interferon Res; 1985; 5(1):137-46. PubMed ID: 2985716
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.
Henke A; Wagner E; Whitton JL; Zell R; Stelzner A
J Virol; 1998 Oct; 72(10):8327-31. PubMed ID: 9733878
[TBL] [Abstract][Full Text] [Related]
8. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
[TBL] [Abstract][Full Text] [Related]
9. Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid.
Kern ER; Overall JC; Glasgow LA
Antimicrob Agents Chemother; 1975 Jun; 7(6):793-800. PubMed ID: 1155920
[TBL] [Abstract][Full Text] [Related]
10. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
[TBL] [Abstract][Full Text] [Related]
11. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
Yin L; Chai D; Yue Y; Dong C; Xiong S
Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
[TBL] [Abstract][Full Text] [Related]
12. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
13. Treatment of intracranial alphavirus infections in mice by a combination of specific antibodies and an interferon inducer.
Coppenhaver DH; Singh IP; Sarzotti M; Levy HB; Baron S
Am J Trop Med Hyg; 1995 Jan; 52(1):34-40. PubMed ID: 7531956
[TBL] [Abstract][Full Text] [Related]
14. Post-exposure prophylaxis of murine rabies with polyinosinic-polycytidylic acid and chlorite-oxidized amylose.
Harmon MW; Janis B; Levy HB
Antimicrob Agents Chemother; 1974 Oct; 6(4):507-11. PubMed ID: 4157354
[TBL] [Abstract][Full Text] [Related]
15. T cells expressing the Vgamma1 T-cell receptor enhance virus-neutralizing antibody response during coxsackievirus B3 infection of BALB/c mice: differences in male and female mice.
Huber S; Sartini D
Viral Immunol; 2005; 18(4):730-9. PubMed ID: 16359239
[TBL] [Abstract][Full Text] [Related]
16. Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.
Antoniak S; Tatsumi K; Bode M; Vanja S; Williams JC; Mackman N
J Innate Immun; 2017; 9(2):181-192. PubMed ID: 27820939
[TBL] [Abstract][Full Text] [Related]
17. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
Yue Y; Xu W; Hu L; Jiang Z; Xiong S
Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
[TBL] [Abstract][Full Text] [Related]
18. [Production of interferon and virus-neutralizing antibodies in adult mice infected with enteroviruses during the neonatal period].
Priimiagi LS; Iyks SR; Kul'berg AIa
Biull Eksp Biol Med; 1978 Mar; 85(3):314-6. PubMed ID: 667327
[TBL] [Abstract][Full Text] [Related]
19. Vaccination procedures against Coxsackievirus-induced heart disease.
Henke A; Jarasch N; Wutzler P
Expert Rev Vaccines; 2003 Dec; 2(6):805-15. PubMed ID: 14711363
[TBL] [Abstract][Full Text] [Related]
20. Anti-mouse IgM immunoglobulin protects weanling mice from Coxsackievirus infection.
Heard HK; Jordan C; Stanton GJ
Microb Pathog; 1989 Dec; 7(6):399-409. PubMed ID: 2560114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
